Literature DB >> 29863942

Autocrine and paracrine regulatory functions of platelet serotonin.

Elmina Mammadova-Bach1, Maximilian Mauler2, Attila Braun1, Daniel Duerschmied2.   

Abstract

Platelets serotonin (5-hydroxytrytamine, 5-HT) uptake and storage in dense granules is tightly regulated by the serotonergic transport system in the blood. Several 5-HT transporters (5-HTTs) have been identified in the vasculature and blood cells, beyond them 5-HTT is the major 5-HT transporter in platelets. Abnormal 5-HT concentrations in the blood plasma or increased platelet 5-HT uptake or abnormal release contribute to the development of various diseases in the vasculature. Consequently, several clinical trials suggested the positive therapeutic effects of 5-HTT blockade in the circulation. Inhibition of 5-HT strongly attenuates autocrine and paracrine functions of platelets, influencing platelet aggregation, vascular contraction, permeability, tissue repair, wound healing, immunity and cancer. Here, we highlight the current state of basic biological research regarding the hemostatic and non-hemostatic functions of platelet-derived 5-HT in normal and disease conditions. We also describe the physiological consequences of targeting platelet 5-HT functions in thrombosis, stroke, inflammation and cancer to overcome common health problems.

Entities:  

Keywords:  Immune functions; platelet serotonin; signaling; tryptophan hydroxylase

Mesh:

Substances:

Year:  2018        PMID: 29863942     DOI: 10.1080/09537104.2018.1478072

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  16 in total

Review 1.  Mechanisms supporting potential use of bone marrow-derived mesenchymal stem cells in psychocardiology.

Authors:  Jianyang Liu; Lijun Zhang; Meiyan Liu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 2.  Neurotransmitters: emerging targets in cancer.

Authors:  Shu-Heng Jiang; Li-Peng Hu; Xu Wang; Jun Li; Zhi-Gang Zhang
Journal:  Oncogene       Date:  2019-09-16       Impact factor: 9.867

3.  Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1/STAT3/ERK1/2 and adenylate cyclase/PKA, respectively.

Authors:  Mauro Sola-Penna; Larissa P Paixão; Jessica R Branco; Alan C Ochioni; Jamille M Albanese; Davi M Mundim; Daniela Baptista-de-Souza; Claudia P Figueiredo; Wagner S Coelho; Mariah C Marcondes; Patricia Zancan
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

4.  Platelet activation in experimental murine neonatal pulmonary hypertension.

Authors:  Pavel Davizon-Castillo; Ayed Allawzi; Matthew Sorrells; Susan Fisher; Kristina Baltrunaite; Keith Neeves; Eva Nozik-Grayck; Jorge DiPaola; Cassidy Delaney
Journal:  Physiol Rep       Date:  2020-03

Review 5.  Platelets in chronic liver disease, from bench to bedside.

Authors:  Pierluigi Ramadori; Thomas Klag; Nisar Peter Malek; Mathias Heikenwalder
Journal:  JHEP Rep       Date:  2019-10-25

Review 6.  Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury.

Authors:  David Stegner; Vanessa Klaus; Bernhard Nieswandt
Journal:  Front Immunol       Date:  2019-11-01       Impact factor: 7.561

7.  The Role of Serotonin in Concanavalin A-Induced Liver Injury in Mice.

Authors:  Qing Pang; Hao Jin; Xiquan Ke; Zhongran Man; Yong Wang; Yi Tan; Zheng Lu; Huichun Liu
Journal:  Oxid Med Cell Longev       Date:  2020-01-06       Impact factor: 6.543

Review 8.  Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.

Authors:  Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

Review 9.  Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases.

Authors:  Minjie Wan; Lili Ding; Dong Wang; Jiawen Han; Pujun Gao
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

Review 10.  Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020.

Authors:  Peter Everts; Kentaro Onishi; Prathap Jayaram; José Fábio Lana; Kenneth Mautner
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.